KR20050110681A - 2-(부틸-1-설포닐아미노)-ｎ-[1(ｒ)-(6-메톡시피리딘-3-일)-프로필]-벤즈아미드, 약물로서의 이의 용도, 및 이를함유하는 약제학적 제제 - Google Patents

2-(부틸-1-설포닐아미노)-ｎ-[1(ｒ)-(6-메톡시피리딘-3-일)-프로필]-벤즈아미드, 약물로서의 이의 용도, 및 이를함유하는 약제학적 제제 Download PDF

Info

Publication number
KR20050110681A
KR20050110681A KR1020057017498A KR20057017498A KR20050110681A KR 20050110681 A KR20050110681 A KR 20050110681A KR 1020057017498 A KR1020057017498 A KR 1020057017498A KR 20057017498 A KR20057017498 A KR 20057017498A KR 20050110681 A KR20050110681 A KR 20050110681A
Authority
KR
South Korea
Prior art keywords
methoxypyridin
sulfonylamino
butyl
propyl
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020057017498A
Other languages
English (en)
Korean (ko)
Inventor
요아힘 브렌델
하인츠 괴겔라인
클라우스 비르트
게르트 울리히 퀴르첼
Original Assignee
사노피-아벤티스 도이칠란트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피-아벤티스 도이칠란트 게엠베하 filed Critical 사노피-아벤티스 도이칠란트 게엠베하
Publication of KR20050110681A publication Critical patent/KR20050110681A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
KR1020057017498A 2003-03-18 2004-03-05 2-(부틸-1-설포닐아미노)-ｎ-[1(ｒ)-(6-메톡시피리딘-3-일)-프로필]-벤즈아미드, 약물로서의 이의 용도, 및 이를함유하는 약제학적 제제 Ceased KR20050110681A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10312073A DE10312073A1 (de) 2003-03-18 2003-03-18 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen
DE10312073.4 2003-03-18

Publications (1)

Publication Number Publication Date
KR20050110681A true KR20050110681A (ko) 2005-11-23

Family

ID=32920928

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057017498A Ceased KR20050110681A (ko) 2003-03-18 2004-03-05 2-(부틸-1-설포닐아미노)-ｎ-[1(ｒ)-(6-메톡시피리딘-3-일)-프로필]-벤즈아미드, 약물로서의 이의 용도, 및 이를함유하는 약제학적 제제

Country Status (21)

Country Link
EP (1) EP1606237A1 (https=)
JP (1) JP2006520343A (https=)
KR (1) KR20050110681A (https=)
CN (1) CN100361943C (https=)
AR (1) AR043622A1 (https=)
AU (1) AU2004222137A1 (https=)
BR (1) BRPI0408441A (https=)
CA (1) CA2519022A1 (https=)
DE (1) DE10312073A1 (https=)
HR (1) HRP20050815A2 (https=)
MA (1) MA27749A1 (https=)
MX (1) MXPA05009763A (https=)
MY (1) MY176510A (https=)
NO (1) NO20054472L (https=)
NZ (1) NZ542476A (https=)
PE (1) PE20050307A1 (https=)
RS (1) RS20050690A (https=)
RU (1) RU2333202C2 (https=)
TW (1) TW200500342A (https=)
WO (1) WO2004083157A1 (https=)
ZA (1) ZA200506328B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009931A1 (de) * 2004-02-26 2005-09-15 Aventis Pharma Deutschland Gmbh Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
DE102005028845A1 (de) * 2005-06-22 2006-12-28 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
WO2007015775A2 (en) * 2005-07-22 2007-02-08 Merck & Co., Inc. Potassium channel inhibitors
EP2435407B1 (en) * 2009-05-29 2019-12-25 RaQualia Pharma Inc. Aryl substituted carboxamide derivatives as calcium or sodium channel blockers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0472053B1 (en) * 1990-08-20 1998-06-17 Eisai Co., Ltd. Sulfonamide derivatives
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
PE20050307A1 (es) 2005-06-08
DE10312073A1 (de) 2004-09-30
TW200500342A (en) 2005-01-01
HK1086819A1 (en) 2006-09-29
RU2005132163A (ru) 2006-04-10
RS20050690A (sr) 2008-04-04
MY176510A (en) 2020-08-12
WO2004083157A1 (de) 2004-09-30
RU2333202C2 (ru) 2008-09-10
ZA200506328B (en) 2006-04-26
MA27749A1 (fr) 2006-02-01
MXPA05009763A (es) 2006-01-27
CN100361943C (zh) 2008-01-16
BRPI0408441A (pt) 2006-04-04
JP2006520343A (ja) 2006-09-07
NZ542476A (en) 2008-05-30
CN1756728A (zh) 2006-04-05
AU2004222137A1 (en) 2004-09-30
AR043622A1 (es) 2005-08-03
NO20054472L (no) 2005-09-27
CA2519022A1 (en) 2004-09-30
HRP20050815A2 (en) 2006-09-30
EP1606237A1 (de) 2005-12-21

Similar Documents

Publication Publication Date Title
JP4051283B2 (ja) オルト−置換およびメタ−置換ビスアリール化合物、その製造法、医薬としてのその使用、並びにそれを含有する医薬製剤
EP0920438B1 (en) N6 heterocyclic substituted adenosine derivatives
JP4445198B2 (ja) カリウムチャンネルインヒビターとして使用するためのオルソ置換含窒素ビスアリール化合物
NO321130B1 (no) Aminocycloheksyleterforbindelser og anvendelser derav
JP2006525227A (ja) アミノシクロヘキシルエーテル化合物およびそれらの用途
JP2007531766A (ja) イオンチャネル調節化合物のプロドラッグおよびその使用
KR20050110681A (ko) 2-(부틸-1-설포닐아미노)-ｎ-[1(ｒ)-(6-메톡시피리딘-3-일)-프로필]-벤즈아미드, 약물로서의 이의 용도, 및 이를함유하는 약제학적 제제
JP4658919B2 (ja) フェニルカルボン酸アミドおよびＩＫｒチャンネル遮断剤の組み合わせならびに心房性不整脈を処置するためのその使用
JP2022537518A (ja) 脳神経または心臓保護剤としてのアミノチオール系化合物の使用
Plouvier et al. Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillation
US20050054673A1 (en) Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
US20080081926A1 (en) Sulfonylaminobenzoic acid and salt
JP2008255118A (ja) 抗不整脈薬としてのプリンリボシド
CN117209483B (zh) 苯并呋喃类衍生物及其制备方法和应用
JP2012250998A (ja) イオンチャネル調節化合物の投与レジメ
EP1720549A1 (de) Kv1.5-blocker zur selektiven steigerung der vorhofkontraktilität und behandlung der herzinsuffizienz
JP2003503484A (ja) アミノアルキル誘導体
JP2007505036A (ja) フェニルカルボキサミドとβ−アドレナリン性受容体遮断剤の組み合わせおよびそれらの心房性不整脈の処置のための使用
HK1086819B (en) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]- benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
RU2676328C2 (ru) Циклическое углеводородное соединение
JP2007532576A (ja) 心不整脈治療のための新化合物およびその使用方法
CN121219288A (zh) 用于治疗疾病或障碍的萘啶酮衍生物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050916

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20090227

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110311

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20110528

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20110311

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I